Relating to the provision of an abortion-inducing drug.

This bill requires physicians to be physically present in Texas during an in-person examination when providing abortion-inducing drugs to patients. It directly affects physicians who prescribe these drugs within Texas, prohibiting remote or telemedicine provision. The key mechanism mandates that a physician must be in the state and examine the patient at the time of drug administration, as specified in amended Health and Safety Code Section 171.063(b). Exceptions for out-of-state consultations (e.g., for non-abortion medical services) do not apply to abortion-inducing drugs, as clarified in amended Occupations Code Section 151.056(b-1).